Viii

• The FDA is meeting this Wednesday to gather input from the public and industry stakeholders for the next Prescription Drug User Fee Act, which will set agency priorities for fiscal years 2028–2032. • Health policy firm Aviva Strategies noted in a Friday memo that the FDA's Rare Disease Innovation Hub is working to align the Center for Drug Evaluation and Research and the Center for Biologics Evaluation and Research. • This alignment aims to resolve a longstanding coordination issue for developers creating treatments for rare diseases.

Legislation would allow government to implement evolving single market rules without full parliamentary scrutiny UK politics live – latest updatesMinisters in Britain are planning a new bill, which would bring into force a food and drink trade deal with the EU but also contain powers enabling the government to “dynamically align” with Europe. That will allow the UK to quickly implement evolving single market rules if it determines it is in the national interest, without having to face full parliamentary scrutiny. Continue reading...